These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 3310318

  • 1. Metformin decreases the high plasminogen activator inhibition capacity, plasma insulin and triglyceride levels in non-diabetic obese subjects.
    Vague P, Juhan-Vague I, Alessi MC, Badier C, Valadier J.
    Thromb Haemost; 1987 Jun 03; 57(3):326-8. PubMed ID: 3310318
    [Abstract] [Full Text] [Related]

  • 2. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
    Juhan-Vague I, Vague P, Alessi MC, Badier C, Valadier J, Aillaud MF, Atlan C.
    Diabete Metab; 1987 Jul 03; 13(3 Pt 2):331-6. PubMed ID: 3115843
    [Abstract] [Full Text] [Related]

  • 3. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
    Kay JP, Alemzadeh R, Langley G, D'Angelo L, Smith P, Holshouser S.
    Metabolism; 2001 Dec 03; 50(12):1457-61. PubMed ID: 11735093
    [Abstract] [Full Text] [Related]

  • 4. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW, Elgrably F, Tchobroutsky G, Slama G.
    Diabete Metab; 1986 Aug 03; 12(4):219-24. PubMed ID: 3533670
    [Abstract] [Full Text] [Related]

  • 5. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
    Glueck CJ, Fontaine RN, Wang P, Subbiah MT, Weber K, Illig E, Streicher P, Sieve-Smith L, Tracy TM, Lang JE, McCullough P.
    Metabolism; 2001 Jul 03; 50(7):856-61. PubMed ID: 11436194
    [Abstract] [Full Text] [Related]

  • 6. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR.
    Dan Med Bull; 2002 Feb 03; 49(1):43-60. PubMed ID: 11894723
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Efficacy of metformin in obese and non-obese women with polycystic ovary syndrome: a randomized, double-blinded, placebo-controlled cross-over trial.
    Trolle B, Flyvbjerg A, Kesmodel U, Lauszus FF.
    Hum Reprod; 2007 Nov 03; 22(11):2967-73. PubMed ID: 17766923
    [Abstract] [Full Text] [Related]

  • 12. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G, Di Garbo V, Cordova R, Rotolo G, Abruzzese G, Raneli G, De Simone R, Bompiani GD.
    Diabetes Res; 1994 Nov 03; 25(2):85-92. PubMed ID: 7648783
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of the body mass index and triglyceride levels in identifying insulin-sensitive and insulin-resistant variants in Japanese non-insulin-dependent diabetic patients.
    Taniguchi A, Fukushima M, Sakai M, Kataoka K, Nagata I, Doi K, Arakawa H, Nagasaka S, Tokuyama K, Nakai Y.
    Metabolism; 2000 Aug 03; 49(8):1001-5. PubMed ID: 10954017
    [Abstract] [Full Text] [Related]

  • 15. Metformin in the treatment of obesity in subjects with normal glucose tolerance.
    Tankova T, Dakovska L, Kirilov G, Koev D.
    Rom J Intern Med; 2003 Aug 03; 41(3):269-75. PubMed ID: 15526510
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of fibrinolytic and metabolic system parameters in obese patients with polycystic ovary syndrome and women with simple obesity.
    Słopień R, Lewandowski K, Kolacz E, Zawilska K, Warenik-Szymankiewicz A.
    Gynecol Endocrinol; 2006 Nov 03; 22(11):651-4. PubMed ID: 17145652
    [Abstract] [Full Text] [Related]

  • 20. Combined metformin and insulin therapy for patients with type 2 diabetes mellitus.
    Ponssen HH, Elte JW, Lehert P, Schouten JP, Bets D.
    Clin Ther; 2000 Jun 03; 22(6):709-18. PubMed ID: 10929918
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.